Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Enterprise Value (2018 - 2025)

Exagen's Enterprise Value history spans 8 years, with the latest figure at -$32.2 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 46.12% year-over-year to -$32.2 million; the TTM value through Dec 2025 reached -$32.2 million, down 46.12%, while the annual FY2025 figure was -$32.2 million, 46.12% down from the prior year.
  • Enterprise Value reached -$32.2 million in Q4 2025 per XGN's latest filing, up from -$35.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$11.2 million in Q1 2025 to a low of -$118.0 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$54.4 million, with a median of -$36.1 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: crashed 76.77% in 2021, then surged 58.92% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$99.4 million in 2021, then surged by 37.26% to -$62.4 million in 2022, then surged by 41.51% to -$36.5 million in 2023, then surged by 39.62% to -$22.0 million in 2024, then crashed by 46.12% to -$32.2 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Enterprise Value are -$32.2 million (Q4 2025), -$35.7 million (Q3 2025), and -$30.0 million (Q2 2025).